Please assess the completion status of the following clinical trial:

Trial Title: Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with PEG and indication for treatment with long-term oral anticoagulant therapy~* Patients with Atrial Fibrillation~Exclusion Criteria:~* Children under 18 years old.~* Life expectancy \<30 days.~* Lack of informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with PEG and oral anticoagulan treatment (Type: None): Patients with PEG and indication for treatment with long-term oral anticoagulant therapy due to non valvular atrial fibrillation (FNAV), according to the current guidelines.

Based on this trial design, predict the completion outcome and termination type (if applicable).